This inventor holds 1 USPTO granted patent. Top assignees: Chinese Academy of Sciences, Shanghai Institute of Pharmaceutical Industry. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014
Title: The Innovative Contributions of Wen Gao
Introduction
Wen Gao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-HCV medicaments. His innovative work has garnered attention for its potential to improve treatment options for hepatitis C.
Latest Patents
Wen Gao holds a patent for the "Use of 9, 10-anthraquinone compounds." This patent discloses the use of 9,10-anthraquinone compounds of formula (I) or pharmaceutical salts thereof, or plant extracts containing said compounds in the preparation of anti-HCV medicaments. The compounds are noted for being cheap, safe, and effective, primarily derived from traditional Chinese medicines. They exhibit better anti-HCV effects with lighter side effects, making them a valuable addition to the pharmaceutical landscape.
Career Highlights
Throughout his career, Wen Gao has worked with esteemed institutions such as the Shanghai Institute of Pharmaceutical Industry and the Chinese Academy of Sciences. His research has focused on the intersection of traditional medicine and modern pharmaceutical practices, leading to innovative solutions in treating viral infections.
Collaborations
Wen Gao has collaborated with notable colleagues, including Jue Hu and Jin Zhong. Their combined expertise has contributed to the advancement of research in the field of pharmaceuticals.
Conclusion
Wen Gao's contributions to the field of pharmaceuticals, particularly through his patent on 9,10-anthraquinone compounds, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to inspire advancements in the treatment of hepatitis C and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile